These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25727766)

  • 1. The use of agomelatine in OCD: effects on the motivational aspects and dysregulated circadian rhythms.
    Perugi G; Quaranta G; Bucci N
    Expert Opin Investig Drugs; 2015 May; 24(5):705-13. PubMed ID: 25727766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian rhythms in obsessive-compulsive disorder.
    Lange KW; Lange KM; Hauser J; Tucha L; Tucha O
    J Neural Transm (Vienna); 2012 Oct; 119(10):1077-83. PubMed ID: 22543530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is circadian rhythm disruption important in obsessive-compulsive disorder (OCD)? A case of successful augmentation with agomelatine for the treatment of OCD.
    da Rocha FF; Correa H
    Clin Neuropharmacol; 2011; 34(4):139-40. PubMed ID: 21768800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic agomelatine treatment corrects the abnormalities in the circadian rhythm of motor activity and sleep/wake cycle induced by prenatal restraint stress in adult rats.
    Mairesse J; Silletti V; Laloux C; Zuena AR; Giovine A; Consolazione M; van Camp G; Malagodi M; Gaetani S; Cianci S; Catalani A; Mennuni G; Mazzetta A; van Reeth O; Gabriel C; Mocaër E; Nicoletti F; Morley-Fletcher S; Maccari S
    Int J Neuropsychopharmacol; 2013 Mar; 16(2):323-38. PubMed ID: 22310059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agomelatine augmentation in obsessive compulsive disorder: a preliminary report.
    Tzavellas E; Karaiskos D; Ilias I; Liappas I; Paparrigopoulos T
    Psychiatriki; 2014; 25(3):179-84. PubMed ID: 25367661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bidirectional communication between sleep and circadian rhythms and its implications for depression: lessons from agomelatine.
    Pandi-Perumal SR; Moscovitch A; Srinivasan V; Spence DW; Cardinali DP; Brown GM
    Prog Neurobiol; 2009 Aug; 88(4):264-71. PubMed ID: 19454302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian Rhythms in Obsessive-Compulsive Disorder: Recent Findings and Recommendations for Future Research.
    Cox RC; Olatunji BO
    Curr Psychiatry Rep; 2019 Jun; 21(7):54. PubMed ID: 31165330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of case studies testing a melatonergic agonist/ 5HT
    Coles ME; Goodman MH
    J Anxiety Disord; 2020 Jan; 69():102173. PubMed ID: 31877423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agomelatine as chronopsychopharmaceutics restoring circadian rhythms and enhancing resilience to stress: a wishfull thinking or an innovative strategy for superior management of depression?
    Jakovljević M
    Psychiatr Danub; 2011 Mar; 23(1):2-9. PubMed ID: 21448091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep- and circadian rhythm-associated pathways as therapeutic targets in bipolar disorder.
    Bellivier F; Geoffroy PA; Etain B; Scott J
    Expert Opin Ther Targets; 2015 Jun; 19(6):747-63. PubMed ID: 25726988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of agomelatine for the treatment of sleep problems in adults with autism spectrum disorder and co-morbid intellectual disability.
    Ballester P; Martínez MJ; Inda MD; Javaloyes A; Richdale AL; Muriel J; Belda C; Toral N; Morales D; Fernández E; Peiró AM
    J Psychopharmacol; 2019 Nov; 33(11):1395-1406. PubMed ID: 31423939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agomelatine treatment corrects impaired sleep-wake cycle and sleep architecture and increases MT
    Tchekalarova J; Kortenska L; Ivanova N; Atanasova M; Marinov P
    Psychopharmacology (Berl); 2020 Feb; 237(2):503-518. PubMed ID: 31720718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agomelatine for depression: expanding the horizons?
    Norman TR; Olver JS
    Expert Opin Pharmacother; 2019 Apr; 20(6):647-656. PubMed ID: 30759026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical experiences with agomelatine. The inner ear has to be synchronized again].
    MMW Fortschr Med; 2010 Mar; 152(10):46-7. PubMed ID: 20380235
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of the obsessive-compulsive and bipolar disorders comorbidity: pharmacodynamic and pharmacokinetic evaluation.
    Marazziti D; Mucci F; Avella MT; Dell'Oste V; Baroni S; Dell'Osso L
    Expert Opin Drug Metab Toxicol; 2019 Aug; 15(8):619-631. PubMed ID: 31271537
    [No Abstract]   [Full Text] [Related]  

  • 16. Agomelatine: innovative pharmacological approach in depression.
    Popoli M
    CNS Drugs; 2009; 23 Suppl 2():27-34. PubMed ID: 19708723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bipolarity of light and dark: A review on Bipolar Disorder and circadian cycles.
    Abreu T; Bragança M
    J Affect Disord; 2015 Oct; 185():219-29. PubMed ID: 26241867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of obsessive-compulsive disorder successfully treated with agomelatine monotherapy.
    De Berardis D; Serroni N; Campanella D; Olivieri L; Moschetta FS; Conti CM; Conti P; Di Giannantonio M
    J Clin Psychopharmacol; 2012 Apr; 32(2):289-90. PubMed ID: 22388158
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent Advances in the Study of Sleep in the Anxiety Disorders, Obsessive-Compulsive Disorder, and Posttraumatic Stress Disorder.
    Boland EM; Ross RJ
    Psychiatr Clin North Am; 2015 Dec; 38(4):761-76. PubMed ID: 26600107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed circadian rhythms and insomnia symptoms in obsessive-compulsive disorder.
    Cox RC; Olatunji BO
    J Affect Disord; 2022 Dec; 318():94-102. PubMed ID: 36057288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.